ArticleJournal of personalized medicine2022

Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience.

Miguel Cordova-Delgado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.